Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1994 Mar;93(3):1172-8.
doi: 10.1172/JCI117070.

Antibodies Against Transforming Growth Factor-Beta 1 Suppress Intimal Hyperplasia in a Rat Model

Affiliations
Free PMC article

Antibodies Against Transforming Growth Factor-Beta 1 Suppress Intimal Hyperplasia in a Rat Model

Y G Wolf et al. J Clin Invest. .
Free PMC article

Abstract

Intimal hyperplasia is induced by therapeutic vascular interventions and often results in clinically important narrowing of the vascular lumen. Examination of the role of TGF-beta 1 in a rat carotid artery injury model confirmed the presence of a previously reported increase in TGF-beta 1 mRNA in the media of injured arteries. Administration of neutralizing anti- TGF-beta 1 antibodies significantly (P < 0.05) reduced the size of the intimal lesions that developed after carotid balloon injury. A control antibody had no effect. The intimal/medial area ratio was also reduced in the anti-TGF-beta 1 group relative to controls (P < 0.01). Immunohistochemical staining showed that two TGF-beta 1-induced extracellular matrix components, EDA + fibronectin and versican, were greatly increased in the untreated neointimal lesions, but were almost completely absent from the lesions of the anti-TGF-beta 1-treated animals. We conclude that TGF-beta 1 is causally involved in the development of intimal hyperplasia, and that anti-TGF-beta 1 agents may be useful in achieving at least partial control of this condition.

Similar articles

See all similar articles

Cited by 42 articles

See all "Cited by" articles

References

    1. Methods Enzymol. 1982;82 Pt A:803-31 - PubMed
    1. J Am Coll Cardiol. 1991 Feb;17(2):433-9 - PubMed
    1. Lab Invest. 1983 Sep;49(3):327-33 - PubMed
    1. J Biol Chem. 1984 Mar 25;259(6):3955-61 - PubMed
    1. J Cell Biol. 1986 Apr;102(4):1217-23 - PubMed

Publication types

Feedback